Die Suchmaschine für Unternehmensdaten in Europa

EU-Förderung (4.949.449 €): implementierung anD OPeration des Gateways für healTh in BBMRI-ERIC Hor 01.10.2015 EU-Rahmenprogramm für Forschung und Innovation "Horizont"

Auf einen Blick

Text

implementierung anD OPeration des Gateways für healTh in BBMRI-ERIC

"BBMRI-ERIC: the Biobanking and BioMolecular resources Research Infrastructure - European Research Infrastructure Consortium, aims to establish, operate and develop a Pan-European distributed research infrastructure in order to facilitate the access to biological resources as well as facilities and to support high quality biomolecular and biomedical research. The ADOPT BBMRI-ERIC proposal aims at boosting and accelerating implementation of BBMRI-ERIC and its services. Its main deliverables are designed to complete or launch the construction of key Common Services of the Research Infrastructure as required for ESFRI-projects ""under implementation"", reflecting the targets of the European Research Area (ERA). One of the challenges in the post-genomic era is the research on common complex diseases, such as cancer, diabetes and Alzheimer’s disease. Revealing these diseases will depend critically on the study of human biological samples and data from large numbers of patients and healthy individuals. The EU’s ageing population is will result in an increase in many of those diseases and consequently an increased healthcare expenditure for senior citizens. BBMRI-ERIC is a specific European asset having become a fundamental component in addressing the ongoing and future requirements particularly of Europe's health service frameworks, including competitiveness and innovativeness of health-related industries. Its implementation is essential for the understanding of the diversity of human diseases, biological samples and corresponding data, which are required for the development of any new drug or diagnostic assay and are, therefore, critical for the advancement in health research, ultimately leading to personalised medicine. BBMRI-ERIC will provide a gateway access to the collections of the European research community, expertise and services building on the outcome of ADOPT BBMRI-ERIC. "


Geförderte Unternehmen:

Firmenname Förderungssumme
Academisch Ziekenhuis Groningen 0,00 €
Academisch Ziekenhuis Leiden 159.344 €
Biobanks AND Biomolecular Resources Research Infrastructure Consortium (Bbmri-Eric) 3.000.703 €
Centre International de Recherche sur le Cancer 106.949 €
Charite - Universitaetsmedizin Berlin 88.764 €
Deutsches Krebsforschungszentrum Heidelberg 315.803 €
Dokuz Eylul Universitesi 16.387,50 €
Fondation Registre du Cancer 108.313 €
Friedrich-Alexander-Universitaet Erlangen-Nuernberg 315.803 €
Idryma Iatroviologikon Ereunon Akademias Athinon 54.500 €
Institut National de la Sante et de la Recherche Medicale 158.314 €
Istituto Ortopedico Rizzoli 103.530 €
Karolinska Institutet 15.100,46 €
Klinikum DER Technischen Universität München (TUM Klinikum) 15.375,00 €
Latvijas Biomedicinas Petijumu UN Studiju Centrs 10.421,04 €
Masarykuv Onkologicky Ustav 21.950 €
Medizinische Universitat Graz 0,00 €
Norges Teknisk-Naturvitenskapelige Universitet Ntnu 93.448 €
Schweizerischer Nationalfonds ZUR Forderung DER Wissenschaftlichen Forschung 0,00 €
Siec Badawcza Lukasiewicz - Port Polski Osrodek Rozwoju Technologii 22.563 €
Swiss Biobanking Platform 94.063 €
Tartu Ulikool 65.325 €
Terveyden JA Hyvinvoinnin Laitos 0,00 €
Universita' Degli Studi Di Milano-Bicocca 0,00 €
Universita TA Malta 0,00 €
University College London 41.691 €
Uppsala Universitet 129.105 €
Ypourgeio Ygeias 12.000,00 €

Quelle: https://cordis.europa.eu/project/id/676550

Diese Bekanntmachung wurde von Englisch nach Deutsch übersetzt. Die Bekanntmachung bezieht sich auf einen vergangenen Zeitpunkt, und spiegelt nicht notwendigerweise den heutigen Stand wider.